Periodic Reporting for period 1 - TSPO METALLODRUGS (Novel, highly effective and selective anticancer metallodrugs)

This project was aimed at the development of novel, highly effective anticancer metallodrugs that selectively target the mitochondria of cancer cells by combining the favourable cytotoxic properties of gold with the capability of TSPO binders to act as delivery vehicles for...